2016年慕尼黑天疱疮与类天疱疮发病机制会议报告
该会议报告汇总了自身免疫性大疱病在发病率与患病率、合并症与自身抗体反应性及临床变异型关联、标准化血清学诊断、实验小鼠模型与靶向治疗等方面的进展,并提及两项研究者发起的多中心试验提示多西环素和氨苯砜是治疗大疱性类天疱疮的有价值药物。
要点
- 自身免疫性大疱病诊断多可通过标准化且广泛可用的血清学检测系统实现。
- 二肽基肽酶-IV抑制剂相关非炎症性大疱性类天疱疮是合并症与自身抗体反应性关联的示例。
- 多西环素和氨苯砜在大疱性类天疱疮治疗中显示为有价值药物。
核心结论
- 会议在描述自身免疫性大疱病发病率与患病率、关联合并症与自身抗体反应性及临床变异型方面取得相当进展。
- 多数自身免疫性大疱病诊断现在可使用标准化且广泛可用的血清学检测系统实现。
- 两项研究者发起的多中心试验突出多西环素和氨苯砜是治疗大疱性类天疱疮的有价值药物。
研究设计与样本
- 会议由吕贝克和马尔堡皮肤科系及慕尼黑解剖与细胞生物学研究所组织,于2016年9月在慕尼黑举行。
- 会议汇集了来自各大洲致力于自身免疫性大疱病工作的基础科学家和临床医生。
主要发现
- 会议讨论了关于天疱疮自身抗体形成决定因素和角质形成细胞易感性的最新实验数据。
- 在导致细胞间黏附丧失的细胞机制方面,信号转导领域分享了新观点。
- 会议采取重要步骤将天疱疮自身抗体和其他炎症介质效果的部分矛盾且有争议的发现置于背景中。
关键数值与推荐
- 实验小鼠模型正越来越多地用于理解中枢和外周耐受机制并评估更特异性治疗方法。
- 靶向自反应性T和B细胞及抗炎介质的分子包括富马酸二甲酯、磷酸二酯酶4和白细胞三烯B4抑制剂用于类天疱疮疾病,以及嵌合抗原受体T细胞用于天疱疮。
临床怎么用
- 临床可借助标准化且广泛可用的血清学检测系统诊断多数自身免疫性大疱病。
- 在大疱性类天疱疮治疗中,多西环素和氨苯砜可作为有价值药物考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autoimmune blistering diseases are a heterogeneous group of about a dozen complex disorders that are characterized by intraepidermal (pemphigus) and subepidermal blistering (pemphigoid diseases and dermatitis herpetiformis). The Pathogenesis of Pemphigus and Pemphigoid Meeting, organized by the Departments of Dermatology in Lübeck and Marburg and the Institute of Anatomy and Cell Biology, Munich, was held in September 2016 in Munich. The meeting brought together basic scientists and clinicians from all continents dedicating their work to autoimmune blistering diseases. Considerable advances have been made in describing incidences and prevalences of these diseases and linking comorbidities with autoantibody reactivities and clinical variants, for example, dipeptidyl peptidase-IV inhibitor-associated noninflammatory bullous pemphigoid. Although new entities are still being described, diagnosis of most autoimmune blistering diseases can now be achieved using standardized and widely available serological test systems. Various experimental mouse models of pemphigus and pemphigoid disease are increasingly being used to understand mechanisms of central and peripheral tolerance and to evaluate more specific treatment approaches for these disorders, such as molecules that target autoreactive T and B cells and anti-inflammatory mediators, that is, dimethyl fumarate, phosphodiesterase 4, and leukotriene B4 inhibitors in pemphigoid disorders, and chimeric antigen receptor T cells in pemphigus. Very recent experimental data about the immunopathology and the determinants of autoantibody formation and keratinocyte susceptibility in pemphigus were discussed. With regard to cellular mechanisms leading to the loss of cell-cell adhesion, new ideas were shared in the field of signal transduction. Major steps were taken to put the various partly contradictory and controversial findings about the effects of pemphigus autoantibodies and other inflammatory mediators into perspective and broaden our view of the complex pathophysiology of this disease. Finally, two investigator-initiated multicenter trials highlighted doxycycline and dapsone as valuable medications in the treatment of bullous pemphigoid.
引用
- Schmidt E, Spindler V, Eming R, et al. Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016. J Invest Dermatol. 2017. PMID: 28390814. doi:10.1016/j.jid.2017.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。